0001974158-24-000025.txt : 20240411
0001974158-24-000025.hdr.sgml : 20240411
20240411165018
ACCESSION NUMBER: 0001974158-24-000025
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240411
DATE AS OF CHANGE: 20240411
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Enliven Therapeutics, Inc.
CENTRAL INDEX KEY: 0001672619
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811523849
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39247
FILM NUMBER: 24839095
BUSINESS ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 720-647-8519
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
FORMER COMPANY:
FORMER CONFORMED NAME: IMARA Inc.
DATE OF NAME CHANGE: 20160419
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lyssikatos Joseph P
CENTRAL INDEX KEY: 0001967150
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 6200 LOOKOUT ROAD
CITY: BOULDER
STATE: CO
ZIP: 80301
144
1
primary_doc.xml
144
0001967150
XXXXXXXX
LIVE
0001672619
Enliven Therapeutics, Inc.
001-39247
6200 LOOKOUT ROAD
BOULDER
CO
80301
720-647-8519
Lyssikatos Joseph P
Officer
Common
Jefferies LLC
520 Madison Ave
4th Floor
New York
NY
10022
42000
832440.00
41000000
04/11/2024
Nasdaq
Common
06/16/2020
Stock Option Grant
Enliven Therapeutics, Inc
N
42000
06/16/2020
N/A
N
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
01/29/2024
12000
190256.40
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
02/29/2024
12000
197006.76
Joseph Lyssikatos
6200 Lookout Rd
1st Fl
Boulder
CO
80301
Enliven Therapeutics Inc
04/01/2024
12000
223145.64
All sales are to be made pursuant to a previously signed/adopted 10b5-1 selling plan dated 06/26/2023, and all representations regarding material non-public information were made as of the adoption of the plan.
04/11/2024
06/26/2023
Joe Lyssikatos